L. Traykov et al., Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease, EUR J NEUR, 6(4), 1999, pp. 415-421
Controversy exists regarding the apolipoprotein E (ApoE) epsilon 4 allele a
ssociation with vascular dementia (VaD), ranging from increased epsilon 4 f
requency, similar to that found for Alzheimer's disease (AD), to no associa
tion between the epsilon 4 allele and VaD. To clarify further the relations
hip between ApoE alleles polymorphism and cerebrovascular disease (CVD) in
demented and cognitively impaired patients, we examined the ApoE phenotypes
in a sample of 280 patients: 155 with AD, 21 with VaD, 32 with mixed demen
tia (MD), 45 with mild cognitive impairment (MCI) but without CVD, and 27 i
n which vascular disease was the most probable cause of cognitive decline [
vascular mild cognitive impairment (VMCI)]. Our results show that the frequ
ency of the ApoE epsilon 4 allele in patients over 70 years old with clinic
ally diagnosed VaD and VMCI does not differ significantly from that of cont
rols. In contrast, ApoE epsilon 4 allele-bearing individuals had greater ri
sk of having late-onset AD (OR = 8.8; 95% CI 3.7-21.0), or non-vascular cog
nitive impairment (OR = 7.0; 95% CI 2.5-19.0). fur J Neurol 6:415-421 (C) 1
999 Lippincott Williams & Wilkins.